Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerse...

FDA Recall #D-0355-2025 — Class II — March 21, 2025

Recall #D-0355-2025 Date: March 21, 2025 Classification: Class II Status: Ongoing

Product Description

Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-381-01 (individual carton) and NDC 70069-381-10 (10x1 mL carton)

Reason for Recall

Lack of Assurance of Sterility: Media fill with bacterial contamination

Recalling Firm

Somerset Therapeutics Private Limited — Bengaluru, N/A

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

997 vials

Distribution

U.S. Nationwide

Code Information

NDC 70069-381-01; A240467A, exp. date 07/2026; NDC 70069-381-10; A240467C, exp. date 07/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated